Related Experiment Video
Updated: Jul 11, 2026

10:25
Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Published on: June 5, 2021
5.1K
Reprogramming the SARS-CoV-1 Neutralizing Antibody S230 to SARS-CoV-2 via Directed Evolution and Molecular
Inji Jung1,2,3, Dinesh Kumar Sriramulu4, Sun-Gu Lee4
1Department of Biomedical Sciences, Graduate School, Korea University, Seoul 02707, Republic of Korea.
ACS Synthetic Biology
|November 14, 2025
Summary
Researchers reprogrammed a SARS-CoV-1 antibody to target SARS-CoV-2 using directed evolution and molecular docking. The modified antibody neutralized SARS-CoV-2, demonstrating a new platform for adapting antibodies to emerging pathogens.
Area of Science:
- Immunology
- Structural Biology
- Synthetic Biology
Background:
- The SARS-CoV-1 neutralizing antibody S230 lacks activity against SARS-CoV-2.
- Developing broad-spectrum neutralizing antibodies is crucial for pandemic preparedness.
Purpose of the Study:
- To reprogram the antigen specificity of the SARS-CoV-1 antibody S230 to target SARS-CoV-2.
- To investigate the molecular basis of antibody specificity reprogramming.
Main Methods:
- Constructed an error-prone single-chain variable fragment (scFv) library from S230.
- Screened the library using bacterial display against the SARS-CoV-2 receptor-binding domain (RBD).
- Utilized molecular docking and reversion analysis to understand mutation effects.
Main Results:
- Identified IJ36-V, an optimized antibody variant with efficient SARS-CoV-2 neutralization.
- IJ36-V retained cross-reactivity with SARS-CoV-1 RBD, showing extended functional breadth.
- Two specific mutations (R56W and N57Y) were found to cooperatively stabilize the binding interface.
Conclusions:
- A limited set of synergistic mutations can enable antigen recognition of related but divergent targets.
- Established a modular and evolvable platform for antibody reprogramming using synthetic biology.
- Demonstrated rapid adaptation of antibody scaffolds for emerging viral threats.
Related Concept Videos
Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Conjugated Proteins
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Coronavirus
Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...

